cvedb.io
CVE-2015-3965
HIGH · CVSS 8.8
EPSS exploitation probability: 0%
Published 2019-03-23T20:29:00.193 · Last modified 2026-06-17T00:26:33.287

Summary

Hospira Symbiq Infusion System 3.13 and earlier allows remote authenticated users to trigger "unanticipated operations" by leveraging "elevated privileges" for an unspecified call to an incorrectly exposed function.

Affected products

pfizer — symbiq_infusion_system_firmware

Does this affect you?

Add your gear to cvedb and we'll alert you only when pfizer ships something exploited.

Check my exposure →

References

This product uses data from the NVD API but is not endorsed or certified by the NVD. Informational only; not professional security advice.